Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.
Diabetes Obes Metab
; 22(10): 1827-1836, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32476252
Full text:
1
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 1
/
Insulin-Secreting Cells
Limits:
Humans
Language:
En
Year:
2020
Type:
Article